New catheter aims to sharpen liver cancer radiation targeting
NCT ID NCT05743842
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a special catheter (TriNav) helps deliver radiation more accurately to liver tumors. About 19 adults with liver cancer that cannot be removed by surgery will receive a test dose followed by the actual treatment. The goal is to see if the two doses match better than with a standard catheter.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a vaccine help fight Hard-to-Treat cancers?
- A new test could reveal how radiation affects the liver
- Ancient wisdom meets modern oncology: can TCM body types forecast treatment side effects?
- Can an epidural pump beat IV painkillers after liver surgery?
- Could a two-vein embolization trick turn inoperable liver tumors into operable ones?
- Could MRI replace CT for sharper cancer radiation planning?